[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07287163":3,"trial-entities:NCT07287163":307,"trial-summary:NCT07287163":314},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":22,"study_type":27,"primary_purpose":28,"phases":29,"enrollment_info":31,"interventions":34,"primary_outcomes":41,"secondary_outcomes":58,"sex":59,"minimum_age":60,"maximum_age":61,"healthy_volunteers":15,"eligibility_criteria":62,"std_ages":72,"locations":75,"central_contacts":300,"overall_officials":301,"references":305,"see_also_links":306},"NCT07287163","PRAX-628-323","Clinical Trial of Vormatrigine in Adult Patients With Epilepsy","Open Label Extension Clinical Trial of Vormatrigine in Adult Patients With Epilepsy","ENROLLING_BY_INVITATION","2028-12-31","2026-07","2026-08-03","2025-10-27","Praxis Precision Medicines","INDUSTRY",false,"Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy","An open label extension clinical trial to assess the safety and tolerability of vormatrigine in adults with focal or primary generalized tonic-clonic seizures.",[19,20,21],"Epilepsy, Tonic-Clonic","Focal Seizure","Primary Generalized Seizure",[23,24,25,26],"epilepsy","tonic-clonic","seizure","focal","INTERVENTIONAL","TREATMENT",[30],"PHASE3",{"count":32,"type":33},700,"ESTIMATED",[35],{"type":36,"name":37,"description":38,"armGroupLabels":39},"DRUG","vormatrogine","Once daily oral",[40],"Open-label 30 mg\u002Fday vormatrogine for up to 2 years",[42,46,48,50,52,54,56],{"measure":43,"description":44,"timeFrame":45},"To assess the safety and tolerability of vormatrigine in adults with focal or primary generalized tonic-clonic seizures","Incidence and severity of TEAEs including discontinuation of study drug due to TEAEs","Up to 2 years",{"measure":43,"description":47,"timeFrame":45},"Change in tympanic temperature in Celsius",{"measure":43,"description":49,"timeFrame":45},"Change in heart rate in beats per minute",{"measure":43,"description":51,"timeFrame":45},"Change in blood pressure in mm\u002FHg",{"measure":43,"description":53,"timeFrame":45},"Change in respiratory rate in breaths per minute",{"measure":43,"description":55,"timeFrame":45},"The principal investigator (PI) or sub investigator will review the laboratory report and document this review. Any clinically significant adverse changes occurring during the clinical trial will be documented as adverse events.",{"measure":43,"description":57,"timeFrame":45},"Incidence of clinically significant ECG abnormalities",[],"ALL","18 Years","85 Years",{"inclusion":63,"exclusion":66,"raw_text":71},[64,65],"Participant who completed an eligible clinical trial (unless agreed by the sponsor medical monitor), including PRAX-628-212, PRAX-628-321 or other vormatrigine trials, or participant who has received vormatrigine outside of an eligible clinical trial (such as an expanded access program)","Participant who had adequate seizure diary and vormatrigine adherence and had been otherwise adherent to the study procedures in the opinion of the investigator unless deemed unacceptable by sponsor",[67,68,69,70],"Participant who withdrew or discontinued treatment from the treatment period of an eligible clinical trial unless deemed acceptable by the sponsor","Participant who plans to enter another interventional investigational study or is on any prohibited medication","Participant who is pregnant, lactating or planning to become pregnant","Participant who is ineligible for the extension clinical trial in the view of the investigator","Inclusion Criteria:\n\n* Participant who completed an eligible clinical trial (unless agreed by the sponsor medical monitor), including PRAX-628-212, PRAX-628-321 or other vormatrigine trials, or participant who has received vormatrigine outside of an eligible clinical trial (such as an expanded access program)\n* Participant who had adequate seizure diary and vormatrigine adherence and had been otherwise adherent to the study procedures in the opinion of the investigator unless deemed unacceptable by sponsor\n\nExclusion Criteria:\n\n* Participant who withdrew or discontinued treatment from the treatment period of an eligible clinical trial unless deemed acceptable by the sponsor\n* Participant who plans to enter another interventional investigational study or is on any prohibited medication\n* Participant who is pregnant, lactating or planning to become pregnant\n* Participant who is ineligible for the extension clinical trial in the view of the investigator",[73,74],"ADULT","OLDER_ADULT",[76,85,91,97,104,111,118,125,132,139,145,150,156,163,170,176,183,189,196,202,209,215,221,225,231,236,241,246,253,259,264,269,276,282,288,294],{"facility":77,"city":78,"state":79,"zip":80,"country":81,"geoPoint":82},"Praxis Research Site","Miami","Florida","33186","United States",{"lat":83,"lon":84},25.77427,-80.19366,{"facility":77,"city":86,"state":79,"zip":87,"country":81,"geoPoint":88},"Miami Lakes","33016",{"lat":89,"lon":90},25.90871,-80.30866,{"facility":77,"city":92,"state":79,"zip":93,"country":81,"geoPoint":94},"Naples","34116",{"lat":95,"lon":96},26.14234,-81.79596,{"facility":77,"city":98,"state":99,"zip":100,"country":81,"geoPoint":101},"Lafayette","Louisiana","70508",{"lat":102,"lon":103},30.22409,-92.01984,{"facility":77,"city":105,"state":106,"zip":107,"country":81,"geoPoint":108},"Bethesda","Maryland","20817",{"lat":109,"lon":110},38.98067,-77.10026,{"facility":77,"city":112,"state":113,"zip":114,"country":81,"geoPoint":115},"Plymouth","Michigan","48170",{"lat":116,"lon":117},42.37143,-83.47021,{"facility":77,"city":119,"state":120,"zip":121,"country":81,"geoPoint":122},"Chesterfield","Missouri","63005",{"lat":123,"lon":124},38.66311,-90.57707,{"facility":77,"city":126,"state":127,"zip":128,"country":81,"geoPoint":129},"Hackensack","New Jersey","07601",{"lat":130,"lon":131},40.88593,-74.04347,{"facility":77,"city":133,"state":134,"zip":135,"country":81,"geoPoint":136},"Amherst","New York","14226",{"lat":137,"lon":138},42.97839,-78.79976,{"facility":77,"city":140,"state":134,"zip":141,"country":81,"geoPoint":142},"Middletown","10941",{"lat":143,"lon":144},41.44593,-74.42293,{"facility":77,"city":134,"state":134,"zip":146,"country":81,"geoPoint":147},"10016",{"lat":148,"lon":149},40.71427,-74.00597,{"facility":77,"city":151,"state":134,"zip":152,"country":81,"geoPoint":153},"Niagara Falls","14304",{"lat":154,"lon":155},43.0945,-79.05671,{"facility":77,"city":157,"state":158,"zip":159,"country":81,"geoPoint":160},"Philadelphia","Pennsylvania","19107",{"lat":161,"lon":162},39.95238,-75.16362,{"facility":77,"city":164,"state":165,"zip":166,"country":81,"geoPoint":167},"El Paso","Texas","79912",{"lat":168,"lon":169},31.75872,-106.48693,{"facility":77,"city":171,"state":165,"zip":172,"country":81,"geoPoint":173},"Houston","77058",{"lat":174,"lon":175},29.76328,-95.36327,{"facility":77,"city":177,"state":178,"country":179,"geoPoint":180},"Porto Alegre","Rio Grande do Sul","Brazil",{"lat":181,"lon":182},-30.03283,-51.23019,{"facility":77,"city":184,"state":185,"country":179,"geoPoint":186},"São José do Rio Preto","São Paulo",{"lat":187,"lon":188},-20.81972,-49.37944,{"facility":77,"city":190,"zip":191,"country":192,"geoPoint":193},"Bielefeld","33617","Germany",{"lat":194,"lon":195},52.03333,8.53333,{"facility":77,"city":197,"zip":198,"country":192,"geoPoint":199},"Tübingen","72076",{"lat":200,"lon":201},48.52266,9.05222,{"facility":77,"city":203,"state":204,"country":205,"geoPoint":206},"Pozzilli","Isernia","Italy",{"lat":207,"lon":208},41.51142,14.06252,{"facility":77,"city":210,"state":211,"country":205,"geoPoint":212},"Bosisio Parini","Lecco",{"lat":213,"lon":214},45.80075,9.29,{"facility":77,"city":216,"zip":217,"country":205,"geoPoint":218},"Milan","20133",{"lat":219,"lon":220},45.46427,9.18951,{"facility":77,"city":92,"country":205,"geoPoint":222},{"lat":223,"lon":224},40.85216,14.26811,{"facility":77,"city":226,"zip":227,"country":205,"geoPoint":228},"Pavia","27100",{"lat":229,"lon":230},45.19205,9.15917,{"facility":77,"city":232,"country":205,"geoPoint":233},"Pisa",{"lat":234,"lon":235},43.70853,10.4036,{"facility":77,"city":237,"country":205,"geoPoint":238},"Ponderano",{"lat":239,"lon":240},45.53846,8.05592,{"facility":77,"city":242,"country":205,"geoPoint":243},"Roma",{"lat":244,"lon":245},44.99364,11.10642,{"facility":77,"city":247,"zip":248,"country":249,"geoPoint":250},"Bydgoszcz","85163","Poland",{"lat":251,"lon":252},53.1235,18.00762,{"facility":77,"city":254,"zip":255,"country":249,"geoPoint":256},"Katowice","40123",{"lat":257,"lon":258},50.2597,19.02173,{"facility":77,"city":260,"country":249,"geoPoint":261},"Lublin",{"lat":262,"lon":263},51.25058,22.57009,{"facility":77,"city":265,"country":249,"geoPoint":266},"Warsaw",{"lat":267,"lon":268},52.22977,21.01178,{"facility":77,"city":270,"zip":271,"country":272,"geoPoint":273},"Barcelona","08003","Spain",{"lat":274,"lon":275},41.38879,2.15899,{"facility":77,"city":277,"zip":278,"country":272,"geoPoint":279},"Madrid","28040",{"lat":280,"lon":281},40.4165,-3.70256,{"facility":77,"city":283,"zip":284,"country":272,"geoPoint":285},"Málaga","29010",{"lat":286,"lon":287},36.72016,-4.42034,{"facility":77,"city":289,"zip":290,"country":272,"geoPoint":291},"Terrassa","08222",{"lat":292,"lon":293},41.56667,2.01667,{"facility":77,"city":295,"zip":296,"country":272,"geoPoint":297},"Valencia","46026",{"lat":298,"lon":299},39.47391,-0.37966,[],[302],{"name":303,"affiliation":13,"role":304},"Medical Director","STUDY_DIRECTOR",[],[],{"nct_id":4,"conditions":308,"biomarkers":313},[309,310,311,312],"Generalized Seizure","Partial Seizure","Seizure Disorder","Tonic-Clonic Seizure",[],{"nct_id":4,"found":15,"summary":315,"prompt_version":315},null]